Recombinant Human BD-2(Discontinued)

Source: E.coli
Defensins (alpha and beta) are cationic peptides with a broad spectrum of antimicrobial activity that comprise an important arm of the innate immune system.  The Alpha-defensins are distinguished from the Beta-defensins by the pairing of their three disulfide bonds.  To date, six human Beta-defensins have been identified; BD-1, BD-2, BD-3, BD-4, BD-5 and BD-6.  Beta-defensins are expressed on some leukocytes and at epithelial surfaces.  In addition to their direct antimicrobial activities, they can act as chemoattractants towards immature dendritic cells and memory T cells.  The Beta-defensin proteins are expressed as the C-terminal portion of precursors, and are released by proteolytic cleavage of a signal sequence and, in some cases, a propeptide sequence.  Beta-defensins contain a six-cysteine motif that forms three intra-molecular disulfide bonds.  Recombinant Human BD-2 is a 4.3 kDa protein containing 41 amino acid residues.

Determined by its ability to chemoattract immature human dendritic cells using a concentration of 10.0-100.0 ng/ml.

For Research Use Only. Not for use in diagnostic/therapeutics procedures.